Astragaloside IV protects human cardiomyocytes from hypoxia/reoxygenation injury by regulating miR-101a
出版年份 2020 全文链接
标题
Astragaloside IV protects human cardiomyocytes from hypoxia/reoxygenation injury by regulating miR-101a
作者
关键词
-
出版物
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-11
DOI
10.1007/s11010-020-03743-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Stimulation of P2Y11 receptor protects human cardiomyocytes against Hypoxia/Reoxygenation injury and involves PKCε signaling pathway
- (2019) Lauriane Benoist et al. Scientific Reports
- Controlling Immunity and Inflammation through Integrin-Dependent Regulation of TGF-β
- (2019) Martijn Nolte et al. TRENDS IN CELL BIOLOGY
- Astragaloside IV attenuates myocardial ischemia/reperfusion injury in rats via inhibition of calcium-sensing receptor-mediated apoptotic signaling pathways
- (2018) Bo Yin et al. ACTA PHARMACOLOGICA SINICA
- A Preclinical Systematic Review and Meta-Analysis of Astragaloside IV for Myocardial Ischemia/Reperfusion Injury
- (2018) Qun Zheng et al. Frontiers in Physiology
- MicroRNA-128 contributes to the progression of gastric carcinoma through GAREM-mediated MAPK signaling activation
- (2018) Lu Han et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MiR-320 regulates cardiomyocyte apoptosis induced by ischemia–reperfusion injury by targeting AKIP1
- (2018) Zhi-Qiang Tian et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- MiR-125b suppresses the carcinogenesis of osteosarcoma cells via the MAPK-STAT3 pathway
- (2018) Tao Xiao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Antiphospholipid antibodies enhance rat neonatal cardiomyocyte apoptosis in an in vitro hypoxia/reoxygenation injury model via p38 MAPK
- (2017) Lauren T Bourke et al. Cell Death & Disease
- MicroRNA-98 inhibits TGF-β1-induced differentiation and collagen production of cardiac fibroblasts by targeting TGFBR1
- (2017) Ranran Cheng et al. Human Cell
- Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models
- (2017) Alex Dyson et al. PLOS MEDICINE
- Glutamine protects cardiomyocytes from hypoxia/reoxygenation injury under high glucose conditions through inhibition of the transforming growth factor-β1-Smad3 pathway
- (2016) Hong Zhang et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Astragaloside IV protects cardiomyocytes from anoxia/reoxygenation injury by upregulating the expression of Hes1 protein
- (2016) Huang Huang et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
- (2016) Masato Morikawa et al. Cold Spring Harbor Perspectives in Biology
- MicroRNA-101 protects cardiac fibroblasts from hypoxia-induced apoptosis via inhibition of the TGF-β signaling pathway
- (2015) Xin Zhao et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Evolving Therapies for Myocardial Ischemia/Reperfusion Injury
- (2015) Borja Ibáñez et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inhibition of microRNA-101 attenuates hypoxia/reoxygenation-induced apoptosis through induction of autophagy in H9c2 cardiomyocytes
- (2015) DONGKAI WU et al. Molecular Medicine Reports
- Astragaloside IV Attenuates Injury Caused by Myocardial Ischemia/Reperfusion in Rats via Regulation of Toll-Like Receptor 4/Nuclear Factor-κB Signaling Pathway
- (2015) Meili Lu et al. PHYTOTHERAPY RESEARCH
- Down-Regulation of miR-101 Contributes to Rheumatic Heart Disease Through Up-Regulating TLR2
- (2015) Bingxin Yang MEDICAL SCIENCE MONITOR
- The microRNA-15 family inhibits the TGFβ-pathway in the heart
- (2014) Anke J. Tijsen et al. CARDIOVASCULAR RESEARCH
- Pharmacological inhibition of TGFβ receptor improves Nkx2.5 cardiomyoblast-mediated regeneration
- (2014) Wen-Pin Chen et al. CARDIOVASCULAR RESEARCH
- MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway
- (2014) Xiaolong Tu et al. JOURNAL OF PATHOLOGY
- HIF-1α Signaling Activation by Post-Ischemia Treatment with Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury
- (2014) Jingwen Si et al. PLoS One
- Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor
- (2014) Gemma Vilahur et al. Frontiers in Physiology
- Clematichinenoside Attenuates Myocardial Infarction in Ischemia/Reperfusion Injury both In Vivo and In Vitro
- (2013) Rui Zhang et al. PLANTA MEDICA
- MicroRNA-101 Inhibited Postinfarct Cardiac Fibrosis and Improved Left Ventricular Compliance via the FBJ Osteosarcoma Oncogene/Transforming Growth Factor-β1 Pathway
- (2012) Zhenwei Pan et al. CIRCULATION
- Ischaemia-induced up-regulation of Toll-like receptor 2 in circulating monocytes in cardiogenic shock
- (2011) S. Selejan et al. EUROPEAN HEART JOURNAL
- TLR2 Ligand Induces Protection against Cerebral Ischemia/Reperfusion Injury via Activation of Phosphoinositide 3-Kinase/Akt Signaling
- (2011) C. Lu et al. JOURNAL OF IMMUNOLOGY
- Toll-Like Receptors: New Players in Myocardial Ischemia/Reperfusion Injury
- (2010) Tuanzhu Ha et al. ANTIOXIDANTS & REDOX SIGNALING
- Integrin–TGF-β crosstalk in fibrosis, cancer and wound healing
- (2010) Coert Margadant et al. EMBO REPORTS
- Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti–Toll-Like Receptor-2 Antibody
- (2009) Fatih Arslan et al. CIRCULATION
- The roles of MAPKs in disease
- (2008) Michael C Lawrence et al. CELL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now